Maravai Lifesciences Holdings, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
MRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10770 Wateridge Circle Suite 200, San Diego, California

Insiders trading volume in the past year

Maravai Lifesciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gtcr Investment Xi Llc Director, 10%+ Owner $1.39 B -$97.6 M -6.55% May 28, 2024
William E. Martin III Chief Executive Officer $5.4 M Jan 16, 2024
Rebecca Buzzeo Chief Commercial Officer $2.81 M Mar 15, 2024
Andrew Burch President, Nucleic Acid Production $2.4 M Apr 30, 2024
Carl Hull Executive Chairman, Director $2.33 M Mar 15, 2024
Peter Leddy Chief Administrative Officer $2.17 M Apr 30, 2024
Kevin Herde Chief Financial Officer $1.91 M Apr 30, 2024
Christine Dolan Executive Vice President & General Manager, Cygnus Technologies $1.47 M Apr 30, 2024
Kurt Oreshack General Counsel $1.28 M Apr 30, 2024
Jessica Hopfield Director $1.19 M May 23, 2024
Susannah Gray Director $871 K May 23, 2024
Gregory T. Lucier Director $817 K May 23, 2024
Murali Prahalad Director $706 K May 23, 2024
Anat Ashkenazi Director $655 K May 23, 2024
John DeFord Director $566 K May 23, 2024
Benjamin Daverman Director $527 K May 23, 2024
Sean Laurence Cunningham Director $527 K May 23, 2024
Constantine S. Mihas Director $527 K May 23, 2024
Luke Marker Director $527 K May 23, 2024
Robert B. Hance Director $136 K Nov 19, 2021
Brian Neel Chief Operating Officer, Nucleic Acid Production $85.5 K Feb 15, 2023

Recent Insider Transactions by Companies or Individuals for Maravai Lifesciences Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership